Article
The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction.
Scientific reports - 5 Feb 2018
Quintanal-Villalonga Álvaro, Ojeda-Márquez Laura, Marrugal Ángela, Yagüe Patricia, Ponce-Aix Santiago, Salinas Ana, Carnero Amancio, Ferrer Irene, Molina-Pinelo Sonia, Paz-Ares Luis
Abstract excerpt
The FGFR4-388Arg variant has been related to poor prognosis in several types of cancer, including lung cancer. The mechanism underlying this association has not been addressed in detail in patients with this pathology. Here, we report that this FGFR4 variant induces MAPK and STAT3 activation and causes pro-oncogenic effects in NSCLC in vitro and in vivo. This variant induces the expression of EMT-related genes,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
